Universal Vision Biotechnology Co Ltd (3218) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.125x

Based on the latest financial reports, Universal Vision Biotechnology Co Ltd (3218) has a cash flow conversion efficiency ratio of 0.125x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$521.08 Million ≈ $16.42 Million USD) by net assets (NT$4.16 Billion ≈ $131.04 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 3218 market cap overview for the company's overall valuation and market capitalisation.

Universal Vision Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)

This chart illustrates how Universal Vision Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Universal Vision Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Universal Vision Biotechnology Co Ltd ranked by their cash flow conversion efficiency. Explore 3218 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Oma Saastopankki Oyj HE:OMASP	0.532x
Fittech Co Ltd TW:6706	0.016x
Meteoric Resources NL F:RNF	-0.820x
Taiwan Paiho Ltd TW:9938	0.049x
Archer Ltd. LSE:0RBA	0.017x
Zhongjing Food Co. Ltd. SHE:300908	0.037x
TECSYS Inc. TO:TCS	0.085x
China Resources Medical Holdings Company Limited F:1PH	0.034x

Annual Cash Flow Conversion Efficiency for Universal Vision Biotechnology Co Ltd (2003–2025)

The table below shows the annual cash flow conversion efficiency of Universal Vision Biotechnology Co Ltd from 2003 to 2025. View 3218 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$4.16 Billion ≈ $131.04 Million	NT$1.67 Billion ≈ $52.50 Million	0.401x	-10.00%
2024-12-31	NT$3.76 Billion ≈ $118.33 Million	NT$1.67 Billion ≈ $52.68 Million	0.445x	-4.20%
2023-12-31	NT$3.34 Billion ≈ $105.32 Million	NT$1.55 Billion ≈ $48.95 Million	0.465x	+3.68%
2022-12-31	NT$2.83 Billion ≈ $89.14 Million	NT$1.27 Billion ≈ $39.95 Million	0.448x	+14.47%
2021-12-31	NT$2.33 Billion ≈ $73.36 Million	NT$911.77 Million ≈ $28.73 Million	0.392x	-3.44%
2020-12-31	NT$2.04 Billion ≈ $64.25 Million	NT$827.08 Million ≈ $26.06 Million	0.406x	+64.02%
2019-12-31	NT$1.70 Billion ≈ $53.41 Million	NT$419.18 Million ≈ $13.21 Million	0.247x	+45.68%
2018-12-31	NT$1.61 Billion ≈ $50.69 Million	NT$273.07 Million ≈ $8.60 Million	0.170x	+13.59%
2017-12-31	NT$1.58 Billion ≈ $49.86 Million	NT$236.48 Million ≈ $7.45 Million	0.149x	-32.07%
2016-12-31	NT$1.16 Billion ≈ $36.54 Million	NT$255.13 Million ≈ $8.04 Million	0.220x	+37.79%
2015-12-31	NT$1.15 Billion ≈ $36.22 Million	NT$183.54 Million ≈ $5.78 Million	0.160x	-17.91%
2014-12-31	NT$1.14 Billion ≈ $35.94 Million	NT$221.81 Million ≈ $6.99 Million	0.194x	+16.31%
2013-12-31	NT$1.10 Billion ≈ $34.61 Million	NT$183.66 Million ≈ $5.79 Million	0.167x	+144.36%
2011-12-31	NT$1.14 Billion ≈ $35.88 Million	NT$77.91 Million ≈ $2.45 Million	0.068x	-46.06%
2010-12-31	NT$663.76 Million ≈ $20.91 Million	NT$84.19 Million ≈ $2.65 Million	0.127x	-26.41%
2008-12-31	NT$539.22 Million ≈ $16.99 Million	NT$92.94 Million ≈ $2.93 Million	0.172x	-0.41%
2006-12-31	NT$546.91 Million ≈ $17.23 Million	NT$94.66 Million ≈ $2.98 Million	0.173x	-57.01%
2004-12-31	NT$305.87 Million ≈ $9.64 Million	NT$123.14 Million ≈ $3.88 Million	0.403x	+71.74%
2003-12-31	NT$235.39 Million ≈ $7.42 Million	NT$55.18 Million ≈ $1.74 Million	0.234x	--

About Universal Vision Biotechnology Co Ltd

TWO:3218 Taiwan Medical Care Facilities

Market Cap

$355.02 Million

NT$11.27 Billion TWD

Market Cap Rank

#14085 Global

#563 in Taiwan

Share Price

NT$133.00

Change (1 day)

-0.75%

52-Week Range

NT$123.50 - NT$170.00

All Time High

NT$655.60